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Environmental Estrogens Induce Transcriptionally Active Estrogen Receptor
Dimers in Yeast: Activity Potentiated by the Coactivator RIP140
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We used three yeast genetic systems to investigate the estrogen-like activity ofoctylphenol (OP),
bisphenol-A (BPA), o,p'-DDT, and o,p'-DDE to induce human estrogen receptor (hER) dimer-
ization and transcriptional activation. We have demonstrated that OP, BPA, and o,p'-DDT can
inducehERligand-dependent dimerizationusingayeasttwo-hybridassay.All threexenoestrogens,
plus estradiol, enhanced estrogen response element (ERE)-dependent transcriptional activation of
hER. In the presence ofreceptor intercing protein 140 (RIP140), ERE-dependent activity was
dramatically amplified by 100-fold for estradiol, OP, BPA, and o,p'-DDT. A yeast whole-cell
[3H]estradiol binding assay was developed to determine the site of interaction on the hER. We
determined nonspecific binding by parallel incubations run in the presence of 5 pM unlabelled
estradiol in PCY2 yeast. Attheconcentrations tested, unlabeledesradiol, OP, andBPAdisplaced
[3H]estradiol inthis binding assay, whereas the concentrations ofo,p'-DDT and o,p'-DDE tested
were insufficient to inhibit binding. Incubating yeast in the presence ofincreasing concenions
ofestradiol and OP (1 pM) or BPA (1 PM) neither blocked nor altered the effiect ofestradiol on
hER activity. We observed no agonistic activity of o,p'-DDE in any of the yeast models used.
These results suggest that OP, BPA, and o,p'-DDT exert their estrogen-like activitythrough the
ER in a mannersimilar to that ofestradiol, andthe coactivator RIP140 markedlypotentiates this
activity. Key words: environmental estrogens, estrogen receptor, ligand binding, receptor dimer-
ization, RIP140, xenoestrogens. Environ Health Perspect 108:97-103 (2000). [Online
23 December 1999]
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Environmental estrogens are man-made
chemicals that possess estrogen-like biologic
activity. Some of these compounds, also
called xenoestrogens, are associated with
reproductive failure, abnormal feminization
or masculinization, and altered immune func-
tion in wildlife (1). Many widely distributed
xenoestrogens are industrial by-products.
Octylphenol (OP), a nonionic surfactant,
increases uterineweight in rats (X) andstimu-
lates human breast cancer cell proliferation,
trout vitellogenin gene expression, and other
estrogen receptor-dependent gene transcrip-
tion (3). o,p'-DDT and o,p'-DDE are com-
ponents of commercial DDT that exhibit
estrogen-like activity. o,p'-DDT can increase
the weight, glycogen, water, and RNA con-
tent of mammalian and avian reproductive
tracts (4). Furthermore, o,p'-DDT and o,p'-
DDE have been reported to induce blastocyst
implantation and maintain pregnancy in rats
(5). Bisphenol A (BPA) is used in the manu-
facturing of polycarbonate and has been
shown to bind to the estrogen receptor (ER),
stimulate MCF-7 cell proliferation, and
increase the expression ofprogesterone recep-
tor (6). The majority of xenoestrogens are
structurally distinct from estrogen, making it
difficult to determine whether a compound
is estrogenic on the basis of its chemical
structure alone.
ER, a member of the ligand-dependent
nuclear receptor superfamily of transcription
factors (7), mediates the effects of estrogen.
Estrogen enters the cell and binds to the ER,
resulting in receptor dimerization. The dimer
then binds to specific DNA sequences
termed estrogen response elements (EREs) in
the promoter region ofER-responsive genes.
Once bound to the ERE, the ER influences
gene expression through interactions with
basal transcription factors. In conjunction
with the basal transcription machinery, the
ER associates with a group of novel nudear
proteins, co-modulators, to enhance (8-11)
or suppress (12) transcriptional activity. One
such co-modulator, receptor interacting pro-
tein 140 (RIP140), has been demonstrated to
interact directly with the ER hormone-bind-
ing domain in the presence of estrogen and
to amplify ER-dependent transcriptional
activity (13-15). Recently, RIP140 has been
shown to interact with other nuclear recep-
tors and regulate gene expression (14,16,17).
The complexing of receptor-interactive pro-
teins with the ERserves as an additional level
ofselectivity and responsiveness in the regu-
lation ofestrogen-dependent gene expression.
The mechanism through which environ-
mental estrogens exert their estrogen-like
activity is unknown. We used three yeast
genetic systems to determine whether several
environmental estrogens affect transcriptional
activation of human ER (hER). Also, it is
unclear whether xenoestrogen-induced ER
transactivation could also be influenced by
the coactivator RIP140. Ourdatasuggest that
the estrogen-like activity ofseveral environ-
mental estrogens is mediated via the estrogen
receptor, and that this activity is enhanced by
RIP140. In addition, our binding data sug-
gest that OP and BPA interact with the
receptor through the ligand-binding site.
Materials and Methods
Materials. 4-tert-Octylphenol (OP) and
bisphenol A (BPA) were purchased from
Aldrich Chemical Co., Inc. (Milwaukee, WI).
The DDT analogs 2-(4-chlorobenzene)-2-
(2-chlorobenzene)-1,1,1-trichloroethane
(o,p'-DDT) and 2-(2-chlorophenyl) 2-(4-
chlorophenyl)-1 , 1-dichloroethylene
(o,p'-DDE) were obtained from Supelco Inc.
(Bellefonte, PA); [3H]estradiol (84.1 Ci/mmol)
was acquired from Dupont//NEN (Boston,
MA). The complete supplement mixture
(minus: leucine and tryptophan or leucine,
tryptophan, and uracil) used for selection was
purchasedfrom BIO 101, Inc. (Vista, CA).
Yeaststrains. We used twoyeast strains to
measure ligand-dependent hER dimerization
or induction ofhER-dependent transcription.
The yeast strain PCY2 (MATa Agal4 Agal8O
URA3::GAL1-lacZ lys2-801amber his3-A200
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trpl-A63/eu2ade2-1Olchre) was used to mea-
sure ligand-dependent hER dimerization
(18). The PCY2 yeast strain carries a genom-
ic copy of the GAL4 binding site upstream
ofa lacZreporter. Induction ofhER-depen-
dent transcriptional activity was measured in
the yeast strain RS188N (MATa ade2-1
his3-1 leu2-1 112 trpl-1 ura3-1) (19).
Transformation ofyeast with plasmid DNA
was done using the lithium acetate method
(20). Transformed yeast colonies were select-
ed by culture on synthetic medium lacking
uracil, tryptophan, and/or leucine.
cDNA and constructs. Construction of
GAL4-hER fusion vectors involved cloning
the full-length hER cDNA into the pPC62
(GAL4-DB) and pPC86 (GAL4-TA) fusion
vectors, as previously described (20). hER
cDNA, placed in the SaA site ofpCMV-5,
was digested with Sat and subdoned into the
pBluescript II K+ at the Sat site such that its
transcription was dependent on T7 poly-
merase (T7-hER). T7-hERwasamplifiedwith
T3 primer and an oligonucleotide (5'-GGG
GAT CGT CGA CTC GGT CTG CA-3').
This construct was designed to keep the cor-
rect reading frame intact in the GAL4-hER
vector. The polymerase chain reaction (PCR)
product was directly cloned into GAL4-DB
and GAL4-TA at the Sai site such that, when
expressed, the N-terminal end of the hER
would be fused to the C-terminal end ofDB
and TA. GAL4-DB-hER and GAL4-TA-hER
fusion cDNA were sequenced to confirm the
correct reading frame before transforming
yeast. The two expression vectors were
cotransformed into the PCY2 yeast strain and
used to assess ERdimerization
The RS188N yeast strain was cotrans-
formed with an ERE-dependent reporter
(YRpE2), hER cDNA (YEpE12), and an
empty pPC62. YRpE2 contains two EREs
from the Xenopus vitellogenin-A gene,
upstream of a lacZ gene. YEpE12 expresses
hER fused to ubiquitin and is under the
control of a yeast copper metallothionein
promoter. The copper metallothionein pro-
moter allows for regulated expression ofhER
in yeast by the addition ofexogenous copper
(19). The attachment of ubiquitin to the
amino terminus of proteins such as hER
improves both the quality and quantity of
proteins expressed in yeast (19). Following
expression in yeast, ubiquitin is cleaved from
the fused product, releasing the desired pro-
tein. The cotransformation of an empty
pPC62 vector in the RS188N is used as a
baseline for comparing the effect ofRIP140
on ER-dependent transcription. Yeast carrying
an ERE2-/aZ reporter, hER, and pPC62 was
used to assess ER-dependent transcription.
To construct the yeast RIP140 expression
vector, we first amplified the coding region of
RIP140 cDNA in pEF-BOS vector (15) by
two oligonucleotides: an up-stream primer
(5'-GCG TCG ACG CTT CTA TTG AAC
ATG ACT CAT-3') and a down-stream
primer (5'-GGACTA GTC CAAAAC TGG
ATG GCA GGT-3'). The upstream oligonu-
cleotide flanked the start codon (underlined in
the up-stream primer), and the downstream
primer was designed around the stop codon of
RIP140 cDNA. The upstream primer includ-
ed a Sai restriction site and the downstream
primer contained a SpeI restriction site for fur-
ther doning. The RIP140 PCR product was
then cloned into pBluescript II SK+ at Sai
and SpeI. The RIP140 coding region, released
from pBluescript II SK+ by Sai and SpeI, was
cloned into GAL4-DB (pPC62) at the Sai
and SpeI sites. The GAL4-DB-RIP140 fusion
cDNAwas sequenced to confirm correct read-
ing frame before transforming yeast. pPC62
containing RIP140 cDNAwascotransformed,
along with YEpE12 and YRpE2, into the
RS188N yeaststrain.
Dimerization assay using theyeast two-
hybrid system. Ligand-dependent dimeriza-
tion ofthe hERwas determined by using the
two domains ofthe yeast transcription factor
GAL4, the DNA-binding (DB) domain and
the transcription-activating (TA) domain
(18,20). The functionality ofGAL4 requires
that the DB and the TA domains be juxta-
posed. To exploit the use ofthese domains,
we cloned hER into separate expression vec-
tors (pPC62 and pPC86) such that hER was
expressed as a fusion protein with DB and
with TA. The two fusion plasmids were
cotransformed into the PCY2 yeast strain.
The strategy behind these genetic
manipulations was to design a recording sys-
tem that could be used to quantitate hER
dimerization. If ligand-dependent hER
dimerization occurred, DB and TA fusion
proteins would be brought in close proximi-
ty, reconstituting GAL4 activity. The recon-
stituted GAL4 increases ,B-galactosidase
synthesis via the expression ofa lacZ reporter
gene that is driven by the GALl promoter.
Thus, the production ofI-galactosidase con-
firms the ability of estrogenic ligands to
induce hERdimerization.
Transactivation assay. We assessed the
ability ofenvironmental estrogens to promote
transcriptional activity ofhER in a genetically
manipulated RS188N yeast strain. RS188N
yeast was cotransformed with YEpE12,
YEpE2, and an empty pPC62 vector (see
"cDNA and Constructs") yielding an ERE-
dependent yeast strain. We used ,B-galactosi-
dase activity to quantitate hER-dependent
gene transcription. We also used the yeast
strain RS188N to determine the influence of
RIP140 on xenoestrogen-induced ER tran-
scription activity by cotransforming the yeast
with YEpE12, YEpE2, and RIP14O cDNA
in pPC62.
Ligand treatment. Stock cultures of the
two-hybrid yeast or ERE-dependent yeast
with or without RIP140 were grown in 20
ml synthetic supplemented medium lacking
theappropriate amino acid selection markers;
1% (v/v) ethanol serves as the carbon source.
Cultures were grown at 30°C until reaching
an OD600 (optical density at 600 nm) read-
ing between 1.5 and 2.5 absorbance units
(AU)/ml culture, after which the stock cul-
tures were stored at 40C for up to 1 month.
For ligand treatment, we added a volume of
the stock yeast culture to 1.0 ml ofsupple-
mented synthetic dextrose (SD) medium
such that the initial OD600 was between 0.1
and 0.15 AU/ml culture. PCY2 yeast were
incubated in SD mediumlacking leucine and
tryptophan; RS188N yeast were incubated in
SD medium lacking uracil, tryptophan, and
leucine. Estradiol and test compound stock
solutions were diluted in DMSO such that 1
il ofthe test compound added to 1.0 ml of
culture gave the desired final ligand concen-
tration. Control cultures received an equal
volume of DMSO. Expression of hER was
induced in the ERE-dependent yeast by
adding 100 pM CuSO4. The cultures were
then grown at 30°C in a shaking incubator
(230 rpm) for 16-18 hr, afterwhich the sam-
ples were removed and P-galactosidase was
quantitated.
P-Galactosidase assays. The j-galactosi-
dase assay was used to measure ligand-
dependent dimerization in the two-hybrid
yeast system and hER-dependent transcrip-
tion activity in the ERE-dependent yeast
system. Overnight yeast cultures were added
to Z buffer (60 mM Na2HPO4, 40 mM
NaH P04, 10 mM KCl, 1 mM MgSO4, 50
mM ?3-mercaptoethanol, pH 7.0) containing
sodium dodecyl sulfate (SDS; 0.027%), with
a total volume of 1.1 ml. This was accom-
plished by adding 0.1 ml of PCY2 yeast to
0.7 ml Z buffer and 0.3 ml 0.1% SDS in Z
buffer or 0.05 ml of RS188N yeast to 0.75
ml Z buffer and 0.3 ml 0.1% SDS in Z
buffer. The reaction mixture was preincubat-
ed at 30°C for 10 min. The reaction, started
byadding 0.2 ml ofo-nitrophenyl-j-D-galac-
topyranoside (ONPG; 4.0 mg/ml in Z buffer
containing j-mercaptoethanol and lacking
SDS), was incubated at 30°C for up to 1 hr
and terminated by adding 0.5 ml of 1.0 M
Na2CO3. J3-Galactosidase activity was deter-
mined by the degree ofONPG hydrolysis at
420 nm. Total P-galactosidase units were cal-
culatedaccording to thefollowingequation:
RRU= 1,000x[(OD420)-(1.75xOD55A)I tXvxOD600
where RRU = relative response units; t=
ONPG reaction time (minutes); v= volume
(milliliters) of yeast used in the reaction;
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GD600 = cell density ofyeast at the start of
the assay; and OD550 = light scattering by
yeast debris (20). The concentration ofeach
ligand that gave 50% ofits maximal ,B-galac-
tosidase activity (EC50) was determined by
fitting the data to a four parameter logistic
function, and analyzed by SigmaPlot soft-
ware (SPSS Inc., Chicago, IL).
Receptor binding assays. We determined
the affinities of the various test compounds
and estradiol for hER in a whole yeast cell
binding assay using [3H]17,B-estradiol (84.1
Ci/mmol). The yeast cultures used for the
binding assays were prepared from stock two-
hybrid cultures maintained at 40C bygrowing
fresh cultures in theappropriatevolumeofSD
medium lacking tryptophan and leucine. The
cultures were grown to anOD600 between 0.2
and 0.8 AU/ml culture. This density was
foundtogiveoptimalspecificbinding.
Saturation analysis of[3H]estradiol bind-
ing was performed in 96-well plates by incu-
bating 0.08 ml ofthe yeast culture with 0.02
ml ofvarious concentrations of[3H]estradiol
(0.1-10 nM) for 3 hr at room temperature.
Total assayvolumewas 0.2 ml made upwith
yeast culture medium. We determined non-
specific binding at each concentration of
ligand by parallel incubations run in the
presence of5 pM unlabeled estradiol. At the
indicated time, we harvested the cells by fil-
tration onto glass filter membranes using a
12-well cell harvester and measured the lev-
els ofbound radioactivity. The specific bind-
ingwas analyzed by the method ofScatchard
to obtain linear regression on a plot of
bound/free versus bound (21). The apparent
dissociation constant (Kd) was calculated
from the slope ofthe regression line, and the
number of binding sites per 1 million cells
was calculated from thex-axis intercept.
We performed competition binding
assays using the same protocol as above,
except that cells were incubated in the pres-
ence of 1 nM [3H]estradiol and various con-
centrations of test compounds (prepared in
DMSO) at a concentration of 1.0 pl com-
pound/200 isl incubation volume to give the
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Figure 1. Dose response for estradiol, OP, BPA, o,p-DDT, and o,p'-DDE in hERtwo-hybrid yeast. (A) Dose
response for estradiol (EC50 = 0.12 ± 0.01 nM) and BPA (EC50 = 3.09 ± 0.05 pM). (B) Dose response for
estradiol, OP(EC50 = 0.43 ± 0.06 pM), o,p-DDT(EC50 = 6.47 ± 0.39 pM), and o,p'-DDE. The curves represent
three to four independent experiments. Values are expressed as mean ± SE of individual samples done in
triplicate. The EC50values arethe mean ± SE ofalltrials.
Table 1. Summary ofthe effects ofestradiol, OP, BPA, o,p'-DDT, and o,p'-DDE on hER.
correct final concentration (estradiol,
10-11-10-7 M; OP, 10-9-3 x 10-5 M; BPA,
10-7-3 x 10-4 M; and o,p'-DDT and o,p'-
DDE, 10-8-1.4 x 10-4 M). Control cells
were incubated under identical conditions
with an equivalent volume of DMSO. We
determined the concentration of unlabeled
ligand required to inhibit 50% binding of
[3H]estradiol (IC50) by fitting the data to a
four parameterlogisticfunction,
f(x)=[(a-d)
(where a = asymptotic maximum, b= slope
parameter, c= value at inflexion point, and d
= asymptotic minimum). We used SigmaPlot
software (SPSS) to analyze the results. The
inhibition constant (A) for each compound
was calculated using the method ofCheng
andPrusoff(22).
Results
Induction ofhER dimerization by environ-
mental estrogens. The hER was expressed in
PCY2 yeast as GAL4-DB-hER and GAL4-
TA-hER fusion proteins. Ligand-dependent
hER dimerization reconstitutes functional
GAL4 activity, resulting in the expression of
a lacZ reporter gene driven by a GALl pro-
moter (20). This provides a powerful means
to investigate ligand-induced protein-protein
interaction. Yeast were grown overnight in
selection medium with varying concentra-
tions ofestradiol, OP, BPA, o,p'-DDT, or
o,p'-DDE. Estradiol generated a sigmoidal
dose-response curve, with 0-galactosidase
activity first being detected at 30 pM and
plateauing at 10 nM; no further stimulation
was observed at higher concentrations
(Figure 1). The EC50 value ofestradiol was
0.12 ± 0.01 nM (mean ± SE). Similarshaped
dose-response curves were observed for OP,
BPA, and o,p'-DDT. The concentrations of
ERE-dependentyeast ERE-dependentyeastwith
hERtwo-hybrid yeast (plus copper) RIP140(minus copper)
,B-Galactosidase Receptor binding P-Galactosidase ,B-Galactosidase K valuesfrom
Compound EC50 Percentof max IC50 Ki EC50 Percent of max EC50 Percent of max literature,
Estradiol 0.12± 0.01 100 5.03±0.84 3.98± 0.63 1.02± 0.31 100 1.28± 0.04 100 1.6(341
(nM( 0.4(30,31,40),
0.8(32), 28(26),
11 (26), 0.05(33)
OP(pM) 0.43 ±0.06 52.6 ± 5.7 1.72 ± 0.57 1.29 ± 0.41 0.70 ± 0.02 74.3 ± 6.7 0.67 ± 0.01 81.9 ± 4.9 2(30), 0.4(31),
0.11 (3)
BPA(pM) 3.09 ±0.05 101.2 8.5 71.0± 2.07 53.38± 1.55 2.15± 0.25 62.4± 0.1 12.16 1.50 53.1 ± 1.2 2(30),6.4(31),
76(6)
o,p DDT(pM) 6.47 ±0.39 16.3 2.5 > 100 > 100 23.8± 8.74 16.6± 3.1 8.17 0.70 16.3± 1.6 69(34),0.4 (33),
0.3(41), 12(32),
120(26), 13(26)
o,p DDE(pM) No effect 0.0 > 100 >100 No effect - Noeffect - 10(41)
max, maximum.
Percent of maximum is the ratio of the maximal 13-galactosidase stimulated by each compound divided by the maximal 3-galactosidase activity induced by estradiol. Values are
expressed asthe mean ± SE of atleastthree independent experiments done intriplicate at each concentration.
'When a K; value was notreported inthe cited literature, one was calculated from availableIC50data usingtheCheng and Prusoffequation (22) and our estradiol Kd value.
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curves represent three to four independent
experiments, with each point done in triplicate.
The EC50 values (mean ± SE) are as follows: estra-
diol (1.02 ± 0.31 nM), OP (0.70 ± 0.02 pM), BPA
(2.15 ± 0.25 PM), and o,p'-DDT (23.80 ± 0.39 PM).
xenoestrogens required to initiate the
reporter gene were > 3,000 times that of
estradiol. BPA began stimulating levels of,-
galactosidase at approximately 100 nM, with
maximal gene expression at 30 pM. OP
began inducing the reporter gene between 10
and1u00 nM, with maximal induction at
approximately 1 pM. o,p'-DDT first induced
hER dimerization at 5 1M, with full induc-
tion at approximately 10 pM. The EC50 val-
ues for OP, BPA, andoip'-DDT were 0.43 ±
0.06 pM, 3.09 ± 0.05 pM, and 6.47 ± 0.39
PM, respectively (Table 1). BPA induced of
galactosidase activity to a level equal to that
induced by estradiol, whereas maximal
induction by OP or op'-DDT was 52.6%
and 16.3%, respectively, of the estradiol
maximum (Table 1). No f3-galactosidase
activity was observed in the presence ofodp-
DDE. Also, when GAL4-DBhER was
expressed in the yeast in the absence of
GAL4-TA-hER, no I3-galactosidase activity
was detected (13,20).
Activation of an ERE-lacZ reporter in
yeast by environmental estrogens. After deter-
mining that xenoestrogens can promote
ER-ER dimerization, we sought to investi-
gate whether such a protein-protein interac-
tion is accompanied by ERE-dependent tran-
scriptional activity in the RS188N yeast. This
yeast expresses hER under the control of a
yeast copper metallothionein promoter and
an ERE-dependent lacZ reporter. The copper
metallothionein promoter allows for regulat-
ed expression ofhER in yeast by the addition
of exogenous copper (19). Estradiol initiated
lacZ production at 100 pM, with maximal
induction reached at 10 nM. The EC50 value
ofestradiol was 1.02 ± 0.31 nM. OP, BPA,
and o,p'-DDT also stimulated hER-depen-
dent gene transcription (Figure 2). OP (EC50
= 0.70 ± 0.02 pM) increased 1-galactosidase
0.051
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Figure 3.Saturation binding of[3H]estradiol in hERtwo-hybrid yeast. cpm, counts per minute. (A) Saturation
binding study. (8) Scatchard analysis. The ligand binding parameters were determined as described in
"Materials and Methods.` The Kd (3.00 + 0.24 nM) and Bmax (9.93 ±3.50fmoles/106 cells) values (mean ± SE)
representthree separate experiments. Each concentration of[3H]estradiol was run in quadruplicate.
activity beginning at approximately 100 nM
and plateauing at approximately 3 PM. BPA
(EC50 = 2.15 ± 0.25 PM) stimulated the
reporter gene at 300 nM, with maximal stim-
ulation at approximately 10 PM. o,p'-DDT
(EC50 = 23.8 ± 8.74 PM) also stimulated the
reporter gene in a dose-dependent manner.
At 5 PM, o,p'-DDT stimulated (-galactosi-
dase activity, with maximal activity reached
between 50 pM and 100 PM. Ofthe xenoe-
strogens tested, OP stimulated the highest
levels of i-galactosidase activity (74.3% of
the maximal estradiol response). As com-
pared to maximal estradiol activity, BPA and
o,p'-DDT stimulated transcriptional activity
to 62.4% and 16.6%, respectively (Table 1),
whereas o,p'-DDE failed to promote ER-
dependent gene transcription (Figure 2).
Although OP was the most potent of the
xenoestrogens tested, OP was 686 times less
potent than estradiol at inducing the ERE-
dependent reporter gene. As compared to
estradiol stimulation off-galactosidase, BPA
and o,p'-DDT were 2,108 and 23,333 times
less potent, respectively.
Inhibition off3H]estradiol binding to
hER by environmental estrogens in whole
yeastcells. The experiments in the two-hybrid
yeast and ERE-dependent yeast systems
demonstrated that xenoestrogens could induce
an active hER dimer. However, the exact site
ofbinding to the receptor remained unknown.
To investigate whether the environmental
estrogens interacted with the ligand-binding
site ofthe hER or at another site, awhole cell
competition bindingassayforyeastwas devel-
oped using [3H]estradiol and the hER two-
hybrid yeast. After determining the optimal
assay conditions, we measured the specific
binding of [3H]estradiol to hER and per-
formed saturation analysis. Saturation analysis
using [3H]estradiol gave a Kd of3.00 ± 0.24
nM, with aBmax (maximum specific binding)
of 9.39 ± 3.5 fmoles/106 cells (Figure 3),
showing that estradiol can transverse the
yeast cell wall and bind to the receptor at
physiologic conditions. The K values for
estradiol and thexenoestrogens were obtained
in the presence of 1 nM [3H]estradiol. OP
(I value = 1.29 ± 0.41 pM) and BPA (Ki value = 53.38 ± 1.55 pM) were able to com-
pete for the labeledligand (Figure 4), where-
as neithero,p'-DDT nor o,p'-DDEdisplaced [3H]estradiol at any concentration tested (up
to 140 pM; data notshown). Estradiol had a
I§ value of3.98 ± 0.63 nM. The rank order
ofligandbinding affinities, highest to lowest,
was estradiol >> OP > BPA. This rank order
corresponds with their observed potency for
stimulating an active hERdimer(Table 1).
Environmental estrogens do not affect
estradiol-induced hER transcrptionalactivi-
ty. Thepreviousexperiments have shown that
both OP and BPA could, in the absence of
estradiol, stimulate ER-dependent gene tran-
scription via binding to the ligand-binding
site of the receptor. However, both OP and
BPA may be present simultaneously with
estradiol in cells. The effect onERE-regulated
gene transcription in the presence ofestradiol
and OP or BPA is unknown. To address this
issue, RS188N yeast were grown in medium
lacking exogenous copper, thus limiting the
production ofhER and maximizing the abili-
ty to detectantagonistic or additive effects on
the estradiol dose-response curve. The con-
centration-dependent response ofestradiol in
RS188N yeast (in the absence ofcopper) was
similar to the response seen when copper was
present (compare Figure 5 to Figure 2). We
observed a copper-dependent increase in
ERE-lacZ activity in RS188N yeast (data not
shown). The EC50 values for estradiol were
0.71 ± 0.07 nM in the absence ofcopper and
1.02 ± 0.31 nM in the presence ofcopper. In
the absence of exogenous copper, estradiol-
induced levels off3-galactosidase were 6-8
RRU, as compared to 100-150 RRU in the
presence of copper. In the absence ofadded
copper, EC50 values for OP (Figure 5A) and
BPA (Figure 5B) were similar, as were their
values in the presence of copper (compare
Figure 5 to Figure 2). Both OP and BPA
stimulated i-galactosidase activity in the
absence or presence of exogenous copper to
approximately the same percent of maximal
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Figure 4. Competition binding studies. Error bars
indicate SE. The curves represent three to five
independent experiments, with ligand concentra-
tions run in triplicate or quadruplicate. The K val-
ues (mean ± SE) for estradiol (3.98 ± 0.63nMW, OP
(1.29 ± 0.41 pM), and BPA (53.38 ± 1.55 pM) repre-
sentthree tofive separate experiments.
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Figure 5. The effect of 1 pM OP (A) or 1 pM BPA (8) on estradiol (E2) dose response in ERE-dependent
yeast grown in the absence of copper. (A) Comparison ofthe OP (1 pM) + E2 curve (EC50 - 2.19 ± 0.20 nM)
with the E2 curve (EC50 = 0.71 ± 0.7 nM) and the OP curve (EC50 = 0.44 ± 0.07 pM). (B) Comparison ofthe
BPA (1 pM) + E2 curve (EC50 = 0.52 ± 0.07 nM) with the E2 curve and the BPA curve (EC50 = 13.45 ± 1.94
pM). Values represent three independent experiments, with each concentration run in triplicate. Error
bars indicate SE. The EC50 values (mean ± SE) representthree independent experiments, exceptthe EC50
value forestradiol, which was from seven experiments.
estradiol activity (66.1 ± 4.0% for OP and
73.2 ± 2.9% for BPA in the absence ofcop-
per; 74.3 ± 6.7% for OP and 62.4 ± 0.1% for
BPA in the presence of copper). Therefore,
copper does not appear to affect hER transac-
tivation. When the xenoestrogens OP (1 gM)
or BPA (1 jiM) were tested in combination
with estradiol, no changes in the maximal [-
galactosidase activity or the EC50 values were
observed (Figure 5).
RIP140 amplifies xenoestrogen-induced
hER activity. Because xenoestrogens show
weak estrogenic activity, we sought to deter-
mine if nuclear receptor coactivators would
influence ER-mediated transcriptional activi-
ty ofhER. We chose to determine the effect
of RIP140 on xenoestrogen-induced ERE-
dependent gene transcription. RIP140 has
been shown to interact with the ER in the
presence ofestradiol, increasing ERE-depen-
dent gene transcription (13,15). To deter-
mine if RIP140 also can increase xenoestro-
gen-stimulated hER-dependent gene tran-
scription, we expressed RIP140 in RS188N
yeast. Although the basic transcription factors
are conserved between yeast and mammalian
cells, yeast appear to lack steroid receptor co-
modulator proteins (14). Therefore, yeast are
ideal for studying the effect co-modulators
might have on nuclear receptor-mediated
transcription. As mentioned above, the ERE-
dependent yeast expressing RIP140 were
grown in medium without added copper.
When RIP140 wascoexpressed withhER, the
maximum [-galactosidase activity stimulated
by estradiol was increased approximately
100-fold over yeast without RIP140 (com-
pare Figure 5 to Figure 6). To investigate if
RIP140 could affect xenoestrogen-induced
hER transactivation, we repeated the experi-
ment using OP, BPA, and o,p'-DDT. Aswith
estradiol, RIP140 increased the maximum
[-galactosidase activity of OP, BPA, and
o,p'-DDT by 100-fold over yeast without
RIP140. The same concentrations ofestradi-
ol, OP, BPA, and o,p'-DDT are required to
initiate and maximally stimulate the reporter
gene in the presence or absence of RIP140
(compare Figure 2 to Figure 6). RIP140 did
not appear to alter the EC50 values for estra-
diol or OP and thus did not alter the potency
of the ligands. However, in the presence of
RIP140, the dose-response curve of BPA
shifted to the right (compare Figure 2 to
Figure 6), resulting in an approximate 6-fold
difference between EC50 values (Table 1).
TheEC50 for o,p'-DDTdecreasedbyapprox-
imately 3-fold in the presence of RIP140
(Table 1). In the absence ofligand, RIP140
did not induce [3-galactosidase activity. Also,
no induction of [3-galactosidase activity was
observed in the presenceofo,p-DDE.
Discussion
The objective ofthis study was to character-
ize the mechanism by which several man-
made nonsteroidal compounds emulate
estrogen in vivo. Using three yeast genetic
systems, we demonstrated that the xenoestro-
gens OP, BPA, and o,p'-DDT exert their
estrogen-like activity through the ER.
In the yeast two-hybrid system, all three
compounds were able to induce ,B-galactosi-
dase activity. This required dimerization of
the two hER fusion proteins to reconstitute
the GAL4 DNA binding protein. These
results support the hypothesis that ER dimer
formation is ligand dependent (20,23). The
results with the RS188N yeast showed that
the ER dimers formed in the presence of
these compounds were able to induce tran-
scription of an ERE-dependent gene. In
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Figure 6. The effect of RIP140 on ligand-induced
,B-galactosidase activity for estradiol, OP, BPA,
o,p-DDT, and o,p'-DDE in the absence of copper.
The curves represent three independent experi-
ments. Values are expressed as the mean ± SE of
each concentration run in triplicate. The EC50val-
ues (mean ± SE) are as follows: estradiol (1.28 ±
0.04 nM), OP (0.67 ± 0.01 pM), BPA (12.16 ± 1.50
pM), and o,p'-DDT(8.17 ± 0.70 pM).
both studies, OP, BPA, and o,p'-DDT
induced [-galactosidase activities at concen-
trations much higher than those required by
estradiol for a similar level ofenzyme activi-
ty. These data are in agreement with in vitro
and in vivostudies which also show that OP,
BPA, and o,p'-DDT possess only weak
estrogen-like activity, including activity in
another yeast genetic system (3,6,24-28).
We also used the RS188N yeast system to
determine what effect OP and BPA would
have on an estrogen-induced gene, given the
possibility that xenoestrogens and estrogen
can simultaneously be present in a cell. In
our study, neither OP nor BPA had any
effect on an estradiol-induced reporter gene.
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Similar results were reported by Milligan et
al. (29). These investigators measured uter-
ine vascular permeability of ovariectomized
mice and found that neither OP nor BPA
altered the stimulatory effect ofestradiol on
vascular permeability.
Because the concentrations of OP, BPA,
and o,p'-DDT required to promote hER
dimerization and transcription were more
than 3,000-times higher than estradiol, we
classified these compounds as weak ER ago-
nists. Another explanation for their weak
estrogen-like activity could be their inability
to cross the yeast cell wall. To address this
issue we performed a whole yeast cell recep-
torbindingassay, which showed that OP and
BPA do bind to the hormone binding site of
the ER. A comparison of AG values for these
compounds from the whole yeast cell-bind-
ing assaywith RGvalues from in vitrobinding
assays showed the values for estradiol, OP,
and BPA to be of a similar magnitude
(3,6,30,31). Thus, our results support the
idea that OP and BPA are indeed weak ER
agonists, and the yeast cell wall does not
inhibit these compounds from entering the
yeast. Although sufficient concentrations of
o,p'-DDT enter our yeast to induce ER
dimerization and ERE-dependent gene tran-
scription, our whole yeast cell-binding assay
may not be sensitive enough to detect com-
petition between o,p'-DDT and [3H]estradi-
ol for ER binding. This is based on previous
cell-free binding studies which demonstrate
that o,p'-DDT can displace [3H]estradiol
from the ER (26,32-35). Furthermore, it has
been demonstrated that o,p'-DDT can tran-
scriptionally activate ER expressed in yeast
(25,26,28). As with our o,p'-DDT binding
results, there is at least one in vitro study
which used spotted seatrout ER that also
failed to show any competition ofo,p'-DDT
with [3H]estradiol (36).
The concentrations of the xenoestrogens
required to elicit a response in the yeast
genetic systems appear to be difficult to
achieve in vivo. However, several reports sug-
gest circumstances under which the local
concentrations of xenoestrogens could be
increased. Many xenoestrogens are hydro-
phobic and can accumulate in fatty tissue,
reaching physiologically relevant concentra-
tions (37). Therefore, adipose tissue might
serve as a xenoestrogen reservoir from which
xenoestrogens could be released in concentra-
tions sufficient to stimulate the ER (37). In
addition, data suggest that environmental
estrogens may not be bound to serum pro-
teins as effectively as estradiol, thus increasing
their bioavailibility and relative concentra-
tions (28,31,38,39). Xenoestrogens could
have a much greater effect on ER-dependent
gene transcription than originally thought in
the presence ofcoactivators such as RIP140.
In our yeast system in which hER and
RIP140 are coexpressed, the coactivator
dramatically increases ER-dependent gene
transcription. The presence of RIP140
increases 17,B-estradiol, OP, BPA, and op'-
DDT induction of ER-dependent gene
transcription by 100-fold. Also, there is the
possibility that RIP140 may slightly alter
the potency of some xenoestrogens such as
BPA and o,p'-DDT. As in yeast lacking
RIP140, o,p'-DDE did not induce ER-
dependent gene transcription in the pres-
ence of RIP140. Previously reported data
from our laboratory clearly demonstrated
that RIP140 directly interacts with the lig-
and-binding domain ofhER in the presence
of estradiol (13). Additionally, the F-
domain of the hER was shown to play an
important regulatory role in the association
ofRIP140 with ER and in ER homodimer-
ization (13). Using the yeast two-hybrid
assay, Nishikawa et al. (40) reported that
the xenoestrogen BPA can induce an inter-
action between the ligand-binding domain
of rat ER and the receptor-interacting
domain of RIP140. They observed BPA-
induced activity with a concentration range
and ratio similar to maximum estradiol
response, as reported in this study. The ratio
of RIP140 to ER has been reported to be
critical for the coactivator to influence ER
transactivation (14,15,17). Therefore, the
effect of xenoestrogens on ER-dependent
gene transcription could be much greater in
cells expressing coactivators than originally
anticipated.
In conclusion, the data presented in this
report indicate that the environmental estro-
gens OP, BPA, and o,p'-DDT posses ER
agonist activity. These compounds were able
to induce the formation ofa transcriptionally
active hER dimer, whose activity was further
enhanced in the presence ofthe ER coactiva-
tor RIP140. OP and BPA appear to activate
the ER through interaction at the estradiol
binding site. As a result, exposure to OP,
BPA, or o,p'-DDT at sufficient concentra-
tions or in the presence ofan ER coactivator
could have deleterious effect on normal cell
function due to the untimely activation of
estrogen-regulated genes.
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